Presentations
Plenary sessions
Tuesday, 31 January 2017
Opening session
Welcome to the HepHIV 2017 Conference in Malta: Objectives and expected outcomes of the Conference
Jürgen Rockstroh, Brian West and Charmaine Gauci
The EU’s contribution to ending the HIV and Hepatitis epidemics in Europe (VIDEO)
Vytenis Andriukaitis, European Commissioner for Health and Food Safety
HIV and Hepatitis Surveillance trends in the EU and feedback from the HIV Presidency conference
Andrew Amato-Gauci, ECDC
HIV and Hepatitis in Europe, time to turn the tide
Masoud Dara, WHO Regional Office for Europe
Do we have the right composition of testing strategies in Europe?
Michel Kazatchkine, UN Secretary-General’s Special Envoy on HIV/AIDS in Eastern Europe and Central Asia
Community perspective on whether we have the right testing strategies in Europe
Jackie Morton, EATG
Wednesday, 1 February 2017
PLE1: Surveillance and monitoring and evaluation of testing
HIV & Viral Hepatitis: What’s Next? (VIDEO)
Alfred Sant, European Parliament
10 years of HIV in Europe – what has been achieved, what remains as challenges
Presentation by Ton Coenen, Rutgers
Presentation by Jens Lundgren, CHIP Rigshospitalet
Test and link to care: How do we measure our success?
Valerie Delpech, PHE
Surveillance of hepatitis and hepatitis testing efforts among people who use drugs
Dagmar Hedrich, EMCDDA
PLE2: Mixing testing strategies: Community and health care settings
Indicator Condition Guided HIV testing – progress and challenges
Ann Sullivan, SSAT
The Euro HIV EDAT Project. Monitoring and evaluation of community based testing: achievements and challenges
Jordi Casabona, Euro HIV EDAT
Home testing for HIV: Feasibility, acceptability, implementation, and applications
Aaron Siegler, Emory University
BCN Checkpoint: achievements, challenges and future plans of a community centre for MSM
Michael Meulbroek, BCN Checkpoint
Special Session on PrEP: Influence of PrEP and new treatment paradigms on testing pathways
HIV testing in sexual health clinics – do they need to change for PrEP?
Sheel Patel, Chelsea and Westminster Hospital
PrEP implemention: Viral hepatitis C testing required?
Maria Prins, Academic Medical Center
Thursday, 2 February 2017
PLE3: Continuum of Care and improving linkage to care
Short report from Conference Day 1 Conference chairs
Brian West
Understanding and improving the HIV Continuum of Care in Europe
Anastasia Pharris, ECDC
The continuum of care and late presentation – implementing the consensus definition in HIV
Amanda Mocroft, UCL
The continuum of care and late presentation – hepatitis - implementing the consensus definition
Jürgen Rockstroh, University of Bonn
The role of civil society in successful testing and linkage to care
Tracy Swan, TAG
PLE4: New point of care diagnostics, affordability and cost-effectiveness
New diagnostics for HIV and HCV testing
Emmanuel Fajardo, MSF
Cost-effectiveness of HIV testing: frequency and target groups
Yazdan Yazdanpanah, INSERM
Closing session
Towards a realistic cure - the role of HIV testing
Brian Gazzard, Chelsea and Westminster Hospital
Conference Call to Action
Jürgen Rockstroh, Conference co-chair
Parallel sessions
Wednesday, 1 February 2017
PS1: Monitoring for HIV and viral hepatitis
PS1/01 Are EU/EEA countries ready to monitor progress on HCV programmes?
Erika Duffell
PS1/02 HIV testing in persons diagnosed with hepatitis B and C
and
Diagnosed HIV infections in persons being tested for the hepatitis B virus: England, 2008-2014
Georgina Ireland
PS1/03 Organizational barriers as an explanation for differences in offer and uptake rates for hepatitis B/C and HIV testing in three drug addiction centres in Copenhagen
Marianne Linnet
PS1/04 Monitoring anonymous HIV testing in Estonia in 2005-2015
Kadi Kallavus
PS1/05 The COBATEST network: A platform to perform monitoring and evaluation of HIV communty-based testing practices in Europe
Laura Fernàndez-López
PS2: Testing strategies in key affected populations
PS2/01 HIV diagnoses in migrants from Western, Central and Eastern Europe in the EU/EEA; emerging epidemics
and HIV diagnoses in migrants from Latin America & Caribbean in Europe; distinct epidemics
Julia del Amo
PS2/02 A high rate of HIV-1 acquisition post immigration among migrants in Sweden determined by a CD4+ T-cell decline trajectory model indicates missed
opportunities for testing and primary prevention
Johanna Brännström
PS2/03 Knowledge, and actual versus potential use of HIV self-testing and self-sampling testing kits in 8 European countries
Cristina Agustí
PS2/04 From HIV-testing to Gay Health Centres: A mapping of European “Checkpoints
Axel Jeremias Schmidt
PS2/05 Drug Related Infectious Diseases (DRID) Medical Doctors Group of OKANA Factors associated with HCV test uptake in heroin
users entering substitution treatment in Greece
Olga Anagnostou
Thursday, 2 February 2017
PS3: Challenges in health care settings: Testing and linkage to care
PS3/01 Assessing the representativeness of European HIV cohort participants as compared to HIV surveillance data
Georgia Vourli
PS3/02 Factors for delayed linkage to care following HIV diagnosis in the WHO European Region
Sara Croxford
PS3/03 Increased HIV case detection through Integration of HIV Testing in Georgian Hepatitis C Elimination Program Screening Activities
Davit Baliashvili
PS3/04 Monitoring HIV-indicator condition based HIV testing in Estonia
Liis Lemsalu
PS3/05 Testing for blood borne viruses in the emergency department of a large London hospital
Daniel Bradshaw
PS4: Community testing
PS4/01 Development of a Toolkit for implementation and evaluation of Checkpoints for MSM
Matthias Kuske
PS4/02 Barring the Way to Health: how legal and regulatory barriers hinder modernising HIV testing across Europe
Lisa Power
PS4/03 BCN Checkpoint: Same-day confirmation of reactive HIV rapid test with Point Of Care PCR test accelerates Linkage to Care and reduces anxiety
Michael Meulbroek
PS4/04 Impact of Pre-Test Counseling Sessions on Increasing Knowledge About HIV and Hepatitis Among the Beneficiaries of a Free of Charge,
Voluntary Counseling and Testing Program (VCT) in Constanta, Romania
Ana-Maria Schweitzer
PS4/05 Checkpoint Collaborative Group Monitoring test uptake and risk behaviour in community based HIV/STI testing sites in
Germany, 2015/2016
Ulrich Marcus
Posters
PO1/PS1: Monitoring for HIV and Viral Hepatitis
PO1/01 Reflex RNA Testing on Hepatitis C Antibody Positive Samples: Is it Being Adopted?
PO1/03 Monitoring HIV Testing Guidance Implementation in Estonia
PO1/04 Core Indicators for Monitoring and Evaluation of Community based Voluntary Counselling and Testing (CBVCT) for HIV in the COBATEST Network, 1st Half 2015 Data
PO1/05 HIV: Are we Testing Appropriately?
PO1/06 Mind the Gap: Exploring Continuum of Care for HIV in Slovenia
PO1/07 Accessibility of HCV Diagnostics and Treatment Services in Eastern Europe and Central Asia (EECA)
PO1/08 Review of Specialty Guidelines on HIV Testing Recommendations for HIV Indicator Conditions in Spain
PO1/12 Has Increased Rollout of DAA Therapy Decreased the Burden of Late Presentation and Advanced Liver Disease in Patients Starting HCV Therapy in Germany?
PO1/13 Availability of HIV Testing in Health Care, Community-based and Home-based Settings in the EU/EEA Member States
PO1/14 Variation in ART-coverage and Virological Suppression among HIV Key Populations
PO1/15 Improving Cascade of Care in Challenging Conditions: Experience from Eastern Siberia
PO1/16 Regional Differences across Europe in Advanced Fibrosis and Cirrhosis among HIV/HCV Co-infected Persons between 2010-2015
PS1/02 HIV Testing in Persons Diagnosed with Hepatitis B and C
and
Diagnosed HIV Infections in Persons Being Tested for the Hepatitis B Virus: England, 2008-2014
PS1/03 Organizational barriers as an explanation for differences in offer and uptake rates for hepatitis B/C and HIV testing in three drug addiction centres in Copenhagen
PS1/04 Monitoring Anonymous HIV Testing in Estonia in 2005-2015
PS1/05 The COBATEST Network: A Platform to Perform Monitoring and Evaluation of HIV Community-based Testing Practices in Europe
PO2/PS2: Testing Strategies in Key Affected Populations
PO2/01 Missed Opportunities for Diagnosing Viral Hepatitis Testing in Europe: a 25-country Analysis
PO2/02 Hepatitis B, C and HIV Testing Uptake in the General, Migrant and Roma Populations in Greece: Results from the Health Examination Survey Hprolipsis
PO2/03 Targeting HIV-stigma within the MSM Community in Italy: Results from a National Survey
PO2/04 Increasing the Impact of Harm Reduction Programs in Response to HIV and HCV Epidemics through Integrated Approach of Testing with Linkage to Care and Treatment
PO2/06 Get Test Project: an Innovative Approach in Attraction of Customers to the Continuum of Services for MSM
PO2/07 Missing Opportunities: Systematic Review on Testing for HCV in Prison Settings
PO2/09 Strategies to Expand Access to Treatment for Hepatitis C and Promote Adherence to HIV Treatment: the Role of Peer Work in a Harm Reduction Centre in Lisbon, Portugal
PO2/10 The “Red Umbrella Athens” Initiative: Presentation of the First Sex Workers’ Drop-In Centre in Athens, Greece
PS2/01 HIV Diagnoses in Migrants from Western, Central and Eastern Europe in the EU/EEA; Emerging Epidemics
PS2/02 A High Rate of HIV-1 Acquisition Post Immigration among Migrants in Sweden Determined by a CD4+ T-cell Decline Trajectory Model Indicates Missed Opportunities for Testing and Primary Prevention
PS2/03 Knowledge, and Actual Versus Potential Use of HIV Self-testing and Self-sampling Testing Kits in 8 European Countries
PS2/04 From HIV-testing to Gay Health Centres: A mapping of European “Checkpoints”
PS2/05 Factors Associated with HCV Test Uptake in Heroin Users Entering Substitution Treatment in Greece
PO3/PS3: Challenges in Health Care Settings and Linkage to Care
PO3/01 Delays in Starting HIV Treatment as Prevention: ART Initiation in the UK
PO3/02 Promoting HIV Testing in Primary Care in East London through a Research Programme is Effective. An MRC Phase IV Implementation Study
PO3/03 Is the Emergency Department (ED) a Suitable Environment to Offer Hepatitis Screening?
PO3/04 Routine HIV Testing in an Inner City Emergency Department- Avoiding Missed Opportunities for Testing
PO3/05 HIV Testing Improvement in Primary Care through Opt-TEST´s Indicator Condition Guided Testing: The Tool-1 and Plan-Do-Study-Act Experience in Catalonia, 2016
PO3/06 One Year after their Commercialization in France, who Use HIV Self-tests?
PO3/07 Population-based Modeling as the First Step in Optimization of HIV Interventions in Ukraine
PO3/08 Psychiatric Symptomatology among Patients with HIV and Hepatitis C - the Experience of a Romanian Clinic
PO3/10 Incidence and Risk Factors for Medical Care Interruption in HIV-Infected Patients
PO3/11 Collaboration with Primary Healthcare Network Significantly Improves Retention in Care and Viral Load Suppression in Ukraine
PS3/01 Assessing the Representativeness of European HIV Cohort Participants as Compared to HIV Surveillance Data
PS3/02 Factors for Delayed Linkage to Care Following HIV Diagnosis in the WHO European Region
PS3/03 Increased HIV Case Detection through Integration of HIV Testing in Georgian Hepatitis C Elimination Program Screening Activities
PS3/04 Monitoring HIV-indicator Condition Based HIV Testing in Estonia
PS3/05 Testing for Blood Borne Viruses in the Emergency Department of a Large London Hospital
PO4/PS4: Community Testing
PO4/01 Euro HIV EDAT Project (WP9/2): HIV-testing Using Oral Fluid Samples and Online Communication of Test Results (Swab2know)
PO4/02 Community Based Screening Network: Combined HIV, Hepatitis and syphilis testing and monitoring - A Community Led Partnership in Portugal
PO4/03 Monitoring and Evaluation of AHF “Test and Treat” Programme in Lithuania
PO4/04 Euro HIV EDAT Project (WP8): A Qualitative Study to Better Understand the Barriers and Facilitators to Early HIV Testing and Linkage to Care among Migrant Populations in Europe (Belgium, Denmark, France, Spain, Portugal)
PO4/05 COBA-Cohort: Preliminary Results of a Pan-European Cohort of HIV Negative MSM in Community-based Voluntary Counselling and Testing Services
PO4/07 CD4 Point-of-care Testing as Intervention Improving Linkage to Care - Lessons Learned from Poland
PO4/08 Euro HIV EDAT (WP4T1): Development of a Self-evaluation Tool in Order to Improve the Impact of the “A Guide to do it Better in our Community Based Voluntary Counselling and Testing (CBVCTs) Centers”
PO4/09 The COBATEST Network: Opportunities and Challenges of a European Network of Community-based Voluntary Counselling and Testing Services for HIV
PO4/11 A Difference. Specific (and Different) Needs of Clients in Two VCT Centres in Southern Poland (Krakow and Rzeszow)
PO4/12 HIV Community Testing Monitoring in Spain
PS4/01 Development of a Toolkit for Implementation and Evaluation of Checkpoints for MSM
PS4/02 Barring the Way to Health: How Legal and Regulatory Barriers Hinder Modernising HIV Testing across Europe
PS4/03 BCN Checkpoint: Same-day Confirmation of Reactive HIV Rapid Test with Point Of Care PCR Test Accelerates Linkage to Care and Reduces Anxiety
PS4/04 Impact of Pre-Test Counseling Sessions on Increasing Knowledge About HIV and Hepatitis Among the Beneficiaries of a Free of Charge, Voluntary Counseling and Testing Program (VCT) in Constanta, Romania
